Tag: pharmaceutical

Recent developments in 340B program litigation impact contract pharmacy arrangements and drug manufacturers nationwide with new court rulings.

A federal court upheld agency discretion in drug origin rulings under the Trade Agreements Act, setting key legal precedent for pharmaceutical contracts.